Apeloa Pharmaceutical Co.,Ltd (SHE: 000739)

Apeloa Pharmaceutical Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,893	3,581	3,553	2,610	2,194	1,036
Trading Asset Securities	0.5	-	0.09	14.89	116.22	463.86
Cash & Short-Term Investments	3,893	3,581	3,553	2,625	2,310	1,500
Cash Growth	5.08%	0.78%	35.36%	13.61%	54.06%	132.73%
Accounts Receivable	2,385	2,243	2,040	1,523	1,256	1,249
Other Receivables	13.95	114.46	116.28	103.74	61.54	86.01
Receivables	2,399	2,358	2,156	1,626	1,318	1,335
Inventory	1,844	2,083	1,802	1,250	1,086	993.04
Prepaid Expenses	-	26.65	20.59	13.06	16.04	8.99
Other Current Assets	645.73	319.99	249.5	267.72	187.1	120.81
Total Current Assets	8,782	8,368	7,781	5,782	4,917	3,958
Property, Plant & Equipment	3,657	3,564	3,406	2,588	1,981	2,018
Long-Term Investments	182.66	174.05	91.41	81.25	121.74	122.21
Goodwill	20.31	20.31	20.31	20.31	20.31	20.31
Other Intangible Assets	312.41	319.8	338.93	346.05	339.9	331.21
Long-Term Deferred Tax Assets	211.39	247.4	270.29	47.58	39.57	49.04
Long-Term Deferred Charges	16.67	20.57	66.21	46.76	11.96	10.21
Other Long-Term Assets	156.85	53.75	47.15	133.22	62.69	13.81
Total Assets	13,339	12,768	12,021	9,045	7,495	6,523
Accounts Payable	4,451	4,127	4,311	2,623	1,929	2,010
Accrued Expenses	194.74	226.43	202.82	221.62	249.4	181.44
Short-Term Debt	871.97	807.8	562.81	332.47	330.28	50
Current Portion of Long-Term Debt	3.75	81.34	0.4	0.2	-	-
Current Portion of Leases	-	7.98	8.65	13.77	-	-
Current Income Taxes Payable	114.92	77.04	80.59	120.56	131.04	61.74
Current Unearned Revenue	375.2	430.37	458.26	302.4	136.19	140.45
Other Current Liabilities	465.19	550.05	402.44	165.8	120.88	117.67
Total Current Liabilities	6,477	6,308	6,027	3,779	2,896	2,562
Long-Term Debt	64.14	18.71	249.62	104.94	-	-
Long-Term Leases	18.18	4.47	15.81	22.95	-	-
Long-Term Unearned Revenue	31.09	30.62	15.12	1.17	125.43	119.8
Long-Term Deferred Tax Liabilities	89.5	103.71	122.96	4.25	10.22	1.24
Other Long-Term Liabilities	72	72	72	72	72	72
Total Liabilities	6,752	6,537	6,502	3,985	3,104	2,755
Common Stock	1,169	1,179	1,179	1,179	1,179	1,179
Additional Paid-In Capital	247	438.01	438.01	438.01	438.01	438.01
Retained Earnings	5,311	4,804	4,096	3,443	2,774	2,152
Treasury Stock	-153.09	-200.2	-200.2	-	-	-
Comprehensive Income & Other	5.58	2.01	-0.79	0.43	0.27	-0.15
Total Common Equity	6,580	6,223	5,512	5,060	4,391	3,768
Minority Interest	7.93	7.69	7.35	-	-	-
Shareholders' Equity	6,588	6,230	5,519	5,060	4,391	3,768
Total Liabilities & Equity	13,339	12,768	12,021	9,045	7,495	6,523
Total Debt	958.03	920.3	837.3	474.33	330.28	50
Net Cash (Debt)	2,935	2,660	2,716	2,151	1,980	1,450
Net Cash Growth	4.78%	-2.03%	26.28%	8.61%	36.59%	4688.29%
Net Cash Per Share	2.52	2.28	2.31	1.82	1.68	1.23
Filing Date Shares Outstanding	1,158	1,169	1,169	1,179	1,179	1,179
Total Common Shares Outstanding	1,158	1,169	1,169	1,179	1,179	1,179
Working Capital	2,305	2,060	1,755	2,003	2,021	1,396
Book Value Per Share	5.68	5.32	4.71	4.29	3.73	3.20
Tangible Book Value	6,247	5,883	5,153	4,694	4,030	3,416
Tangible Book Value Per Share	5.39	5.03	4.41	3.98	3.42	2.90
Buildings	-	1,743	1,743	1,474	1,456	1,466
Machinery	-	4,398	4,126	2,903	2,755	2,624
Construction In Progress	-	545.85	311.4	710.22	158.7	118.85

Source: S&P Capital IQ. Standard template. Financial Sources.